Castle Biosciences, Inc. CSTL
$35.17
$1.735.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.31% | -4.89% | 2.17% | 2.77% | 6.25% |
| Total Receivables | -6.70% | -23.51% | -14.16% | 0.84% | 15.92% |
| Inventory | 26.46% | 52.74% | 26.05% | 31.62% | 4.41% |
| Prepaid Expenses | 26.34% | 26.41% | -3.04% | 31.16% | 64.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -2.17% | -5.86% | 0.26% | 3.71% | 8.82% |
|
|
|||||
| Total Current Assets | -2.17% | -5.86% | 0.26% | 3.71% | 8.82% |
| Net Property, Plant & Equipment | 32.73% | 73.24% | 78.99% | 77.72% | 78.20% |
| Long-term Investments | 0.00% | -0.01% | 0.00% | -0.01% | 0.01% |
| Goodwill | 0.00% | -0.01% | 0.00% | -0.01% | 0.01% |
| Total Other Intangibles | -9.66% | 28.93% | -6.97% | -8.73% | -8.53% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 157.18% | 173.57% | 163.14% | 13.45% | -37.68% |
| Total Assets | 3.02% | 9.19% | 8.91% | 9.37% | 11.78% |
|
|
|||||
| Total Accounts Payable | -26.65% | 76.88% | 171.13% | 79.31% | 38.17% |
| Total Accrued Expenses | 10.54% | 9.92% | 16.54% | 7.70% | 12.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 23.30% | 14.73% | -9.78% | -16.96% | 186.70% |
| Total Finance Division Other Current Liabilities | 164.34% | 90.46% | 72.90% | 500.63% | 220.63% |
| Total Other Current Liabilities | 164.34% | 90.46% | 72.90% | 500.63% | 220.63% |
| Total Current Liabilities | 11.04% | 30.82% | 39.04% | 24.86% | 28.99% |
|
|
|||||
| Total Current Liabilities | 11.04% | 30.82% | 39.04% | 24.86% | 28.99% |
| Long-Term Debt | -11.59% | -5.85% | -1.08% | 0.34% | -19.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.26% | 76.70% | 74.20% | 71.17% | 84.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -49.81% | 356.99% | 138.64% | 12.37% | -- |
| Total Liabilities | 2.01% | 40.68% | 42.82% | 30.24% | 40.89% |
|
|
|||||
| Common Stock & APIC | 5.08% | 5.12% | 5.97% | 5.91% | 6.40% |
| Retained Earnings | -8.77% | -5.68% | -12.07% | -5.83% | -4.47% |
| Treasury Stock & Other | -756.41% | -148.09% | 16.09% | -49.26% | 122.67% |
| Total Common Equity | 3.22% | 4.79% | 3.30% | 5.89% | 7.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.22% | 4.79% | 3.30% | 5.89% | 7.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.22% | 4.79% | 3.30% | 5.89% | 7.43% |
|
|
|||||